Introduction {#s1}
============

Human milk is the optimal nutrition for preterm infants. Increasing evidence has demonstrated that mother\'s own milk provides significant benefits for extremely preterm infants, such as the prevention of infection and necrotizing enterocolitis and a reduction in the duration of hospital stay ([@B1]). In addition, it has been reported that these benefits are modulated according to the dose of human milk fed during hospitalization ([@B2], [@B3]).

Mother\'s own milk is at the top of the biological hierarchy; therefore, it is always preferable to other sources of milk ([@B4]). Nevertheless, donor human milk can be a bridge until a mother\'s own milk is available and sufficient to meet her infant\'s nutritional needs ([@B1], [@B5]). Indeed, in a recent meta-analysis, mother\'s own milk supplemented with donor human milk was associated with a reduced risk in the development of bronchopulmonary dysplasia in very preterm infants compared with that supplemented with preterm formula ([@B6]). In 2014, Quigley and McGuire demonstrated that formula-fed preterm and low birth weight infants had higher rates of short-term growth but also a higher risk of developing necrotizing enterocolitis than those who were fed donor human milk ([@B7]).

The association among early nutrition, growth, growth quality, and the future risk of developing noncommunicable diseases has attracted much interest in recent years.

In a recent study on the growth of late preterm infants, we demonstrated that being fed human milk is associated with increased fat-free mass deposition at term corrected age (CA) ([@B8]).

It has also been reported that formula-fed very preterm infants show an altered body composition. Specifically, compared with breastfed very preterm infants, formula-fed very preterm infants showed increased fat mass at term CA ([@B9], [@B10]), which decreased toward 6 months CA ([@B11]).

Conversely, preterm infants fed fortified mother\'s own milk showed a higher percentage of fat-free mass than formula-fed infants at term CA ([@B12]).

Data regarding the effect of human milk (both fresh mother\'s milk and/or donor human milk) on the modulation of body composition in preterm infants are scarce. Therefore, the aim of this study was to investigate the effect of human milk (both fresh mother\'s milk and/or donor human milk) on growth and body composition in preterm infants.

Materials and methods {#s2}
=====================

The Ethics Committee of the Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore Policlinico approved the study, and written informed consent was obtained from the parents. All clinical investigations were conducted according to the principles outlined in the Declaration of Helsinki.

Study design
------------

A longitudinal observational study was conducted.

Very low birth weight infants (VLBW: birth weight \<1,500 g) born between May 2016 and December 2017 at the authors\' institution with gestational age (GA) at birth from 26^+0^ to 33^+6^ weeks were included in the study.

The exclusion criteria for all infants screened included the presence of congenital diseases, chromosomal abnormalities or cardiac, brain, renal, endocrine or surgical diseases, which can interfere with growth. In addition, infants who required ventilatory assistance and intravenous nutritional support at term CA were excluded.

GA was based on the last menstrual period and first trimester ultrasonogram. CA was calculated using the chronological age and adjusted for GA, which is the number of additional weeks from term (40 weeks) ([@B13]).

Data collection and nutritional practices
-----------------------------------------

Clinical data, anthropometric measurements, and nutritional intake in terms of the volume of human milk intake (both fresh mother\'s milk and/or donor human milk) during the hospital stay were acquired from computerized medical charts (Neocare®).

Parenteral nutrition was started on the first day of life. The parenteral solutions were prepared by the hospital pharmacy according to the medical prescription. The provided volume increased from 80 to 90 ml/kg on the first day to 150--180 ml/kg on the 7th day of life, with an energy/protein ratio from 20.8--24 kcal/g on the first day up to 23.1--27.7 kcal/g on the 7th day of life.

Weaning from parenteral nutrition was scheduled to obtain a weight velocity \>15 g/kg/day. To achieve this goal, the macronutrients were reduced gradually according to weight velocity. Table [1](#T1){ref-type="table"} shows the parenteral nutrition practices according to the internal procedure.

###### 

Parenteral nutrition practices.

  **Day of life**      **1**    **2**   **3**     **4**   **5**      **6**      ≥**7**                                                                       
  -------------------- -------- ------- --------- ------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
  Volume (ml/kg)       80--90   80      90--100   90      110--120   100--110   120--140   110--120   140--160   120--130   150--160   140--150   150--160   150--160
  Glucose (g/kg)       8        9       8         9       9          10--11     9          10--13     10         10--14     10--13     10--14     10--14     10--14
  Lipids (g/kg)        2--2.5   2.5     2.5       2.5     2.5        2.5        3          3          3          3          3          3          3          3
  Proteins (g/kg)      2.5--3   3       3.5       3       3--3.5     3.5        3--3.5     3,5        3.5--4     3,5        4          3,5        4          3,5
  Sodium (mEq/kg)      0        0       0         0       0          0          3          3          3          3          3,5        3.5        4          3.5--4
  Potassium (mEq/kg)   0        0       0         0       0          0          2          2          2          2          2          2          3          2--4
  Cloride (mEq/kg)     0        0       0         0       0          0          3          3          3          3          3.5        3.5        3.5-6      3.5--4
  Calcium (mg/kg)      0        0       60        60      60         70         70         80         80         80         80         80         80         90
  Phosphate (mg/kg)    0        0       30        30      30         40         40         50         50         55         55         60         60         70
  Magnesium (mEq/kg)   0        0       0.5       0.5     0.5        1          0.5        1          0,5        1          0,5        1          0,5        1

*Parenteral nutrition recommendation according to internal procedure (fluids, macronutrients and micronutrients)*.

Enteral feeding was started within 24 h of postnatal life using fresh mother\'s milk. When fresh mother\'s milk was unavailable or insufficient, donor human milk was started following the acquisition of written informed consent from the parents. In case of lack of parents\' consent, infants were fed with preterm formula (energy: 83 kcal/100 ml; carbohydrates: 8.4 g/100 ml; proteins: 2.7 g/100 ml; fat: 4.1 g/100 ml).

For infants with birth weights less than 1,000 g and/or with severe intrauterine growth restriction (\<3th percentile according to INTERGROWTH-21st reference curves) ([@B14]), enteral feeding was started at 10 ml/kg/day and remained stable for the first 3 days of life. On the fourth day of life, an increase of 10 ml/kg/day was scheduled.

For infants with birth weights greater than or equal to 1,000 g without severe intrauterine growth restriction (\<3th percentile according to INTERGROWTH-21st reference curves) ([@B14]), enteral feeding was started at 20 ml/kg/day and remained stable for the first 2 days of life. After the third day of life, an increase of 20 ml/kg/day was scheduled.

Enteral nutrition was stopped in cases of septic shock, needs for exsanguinotrasfusion, abdominal distension with a visible intestinal loop, and gastric residual volumes \>2 ml/kg for infants with birth weights \<750 g, \>3 ml/kg for infants with birth weights ranging from 751 to 1,000 g and \>5 ml/kg for infants with birth weights greater than 1,000 g.

When the infants tolerated an enteral intake ≥80 ml/kg, a target human milk fortification was started.

Specifically, both donor pasteurized human milk and fresh mother\'s milk were analyzed using a mid-ray spectrometry human milk analyzer (Miris AB®).

Pooled donor human milk was created by mixing mature thawed human milk from 1 to 5 donors enrolled at the Human Milk Bank at the authors\' institution. Analyses of fresh mother\'s milk were conducted two times/week using a 10-ml sample from a 24 h fresh milk pool. Analyses of donor human milk were conducted using a 10-ml sample from each pool after Holder pasteurization (62.5°C for 30 min) to account for macronutrient depletion due to storage and pasteurization ([@B15]). According to these results, the medical team prescribed individualized fortification to comply with the ESPGHAN nutrient intake guidelines ([@B16]).

Human milk fortification was performed using bovine human milk fortifiers: FM85 (Nestlè) or Aptamil BMF (Nutricia) as polymeric fortifiers, Aptamil PS (Nutricia) for protein supplementation, and medium-chain triglyceride (MCT) oil (Medifood) for energy provision.

Human milk intake was expressed as the volume of fortified donor human milk and/or fortified fresh mother\'s milk.

The percentage of human milk intake was computed from the volume of human milk intake compared with the total volume of milk intake during the hospital stay (fortified donor human milk+fortified fresh mother\'s milk+formula milk). In addition, the proportion of mothers\' own milk within the total volume of human milk intake was computed (fresh mother\'s milk intake %).

Anthropometric measurements
---------------------------

Body weight, body length and head circumference of all infants included in the study were assessed at birth and at term CA according to standard procedures ([@B17], [@B18]). In detail, a subject\'s body weight was measured on an electronic scale accurate to the nearest 0.1 g (PEA POD Infant Body Composition System; COSMED, Italy), body length was measured to the nearest mm using a recumbent infant length board, and head circumference was measured to the nearest 1 mm using a nonstretch measuring tape.

Infants with birth weights below the 10th percentile according to INTERGROWTH-21st reference curves ([@B14]) were categorized as small for gestational age (SGA).

The weight z-scores at birth and at discharge were calculated according to INTERGROWTH-21st reference and standard curves, respectively ([@B14], [@B18]).

The daily growth rate was calculated using the exponential regression model described by Patel et al. ([@B19]) as follows: $$\begin{array}{l}
{\left\lbrack {1000 \times ln{({W2/W1})}} \right\rbrack/{({D2 - D1})}} \\
\end{array}$$ where W = weight in grams; D = day; 1 = beginning of the time interval; and 2 = end of the time interval ([@B19]).

Body composition assessment
---------------------------

Body composition was assessed at term CA for all infants included in the study using an air-displacement plethysmography system (PEA POD Infant Body Composition System; COSMED, Italy) ([@B20], [@B21]). The PEA POD assesses FM and FFM by body mass and body volume measurements via the application of whole-body densitometric principles. Body density was computed from the study subject\'s measured mass and volume and then converted to indicate the total absolute (g) and percentage (%) of FM and FFM using sex-specific equations developed by Fomon et al. ([@B22]). The observers were health professionals trained to perform anthropometric and body composition measurements according to our standard procedure. The interobserver coefficient of variation for the FM percentage estimates was 0.3%.

Statistical analysis
--------------------

Continuous variables are reported as the mean and standard deviation (SD). Categorical variables are reported as absolute numbers or percentages. Comparisons between infants fed human milk (fresh mother\'s milk or donor human milk) at less than 50% of the total volume of milk intake during the hospital stay (group 1) and infants fed human milk at greater or equal to 50% of the total volume of milk intake during the hospital stay (group 2) were conducted using the X^2^ test for discrete variables and analysis of variance for continuous variables.

Multiple linear regression analyses were conducted to explore the role of fortified human milk in modulating fat-free mass at term CA according to sex and birth weight. Indeed, it has been reported that gender can influence body composition at term CA ([@B23]).

Statistical significance was set at a level of 0.05. All statistical analyses were performed using SPSS software (SPSS, version 20; SPSS, Chicago, IL).

Results {#s3}
=======

Seventy-three VLBW infants were included in the study. The basic characteristics at birth are shown in Table [2](#T2){ref-type="table"}. No differences were detectable at birth between the two study groups.

###### 

Basic characteristics at birth of infants included.

                                                       **All infants (*n* = 73)**   **Group 1 (*n* = 24)**   **Group 2 (*n* = 49)**   ***p***
  ---------------------------------------------------- ---------------------------- ------------------------ ------------------------ ---------
  Weight (g)                                           1248 ± 198                   1207 ± 208               1269 ± 193               0.215
  Length (cm)                                          38.3 ± 2.8                   37.7 ± 3.3               38.6 ± 2.6               0.278
  Head Circumference (cm)                              26.8 ± 1.9                   26.5 ± 2.3               27.0 ± 1.7               0.358
  Gestational age (weeks)                              30.2 ± 2.0                   30.0 ± 2.4               30.3 ± 1.8               0.632
  Males: n (%)                                         32 (43.9)                    10 (41.6)                22 (44.9)                0.797
  Twins: n (%)                                         35 (48.5)                    13 (54.1)                22 (44.9)                0.463
  SGA infants n (%)                                    25 (34.2)                    9 (37.5)                 14 (28.6)                0.305
  Antenatal steroids n (%)                             70 (95.9)                    23 (95.8)                47 (95.9)                0.704
  Need of invasive ventilatory assistance n (%)        17 (23.3)                    5 (20.8)                 12 (24.5)                0.558
  Duration of invasive ventilatory assistance (days)   0.88 ± 2.0                   0.61 ± 1.7               1.0 ± 2.1                0.446
  Need of non-invasive ventilatory assistance n (%)    41 (56.1)                    15 (62.5)                26 (53.1)                0.558
  Duration of invasive ventilatory assistance (days)   20.94 ± 21.0                 19.74 ± 23.7             21.53 ± 19.8             0.741

*Data are expressed as mean ± standard deviation or n (%). The duration of ventilatory assistance were expressed as days of treatment*.

The infants included in the study received parenteral nutrition for 21.9 ± 9.0 days, and full enteral feeding was achieved at 28.9 ± 9.0 days of life; no differences were found between the two groups.

Data regarding human milk intake (fresh mother\'s milk and/or pasteurized donor human milk) are shown in Table [3](#T3){ref-type="table"}.

###### 

Milk volume intake during hospital stay.

                                     **All infants (*n* = 73)**   **Group 1 (*n* = 24)**   **Group 2 (*n* = 49)**   ***p***
  ---------------------------------- ---------------------------- ------------------------ ------------------------ ---------
  Total Milk volume intake (ml)      10357.1 ± 5871.7             11713.1 ± 7756.7         9692.9 ± 4638.5          0.169
  Human milk daily intake (ml/day)   118.2 ± 47.3                 65.6 ± 25.9              144.0 ± 31.2             \<0.001
  Human milk volume intake (ml)      6385.4 ± 3498.9              3998.6 ± 2590.8          7554.4 ± 3302.1          \<0.001
  Human milk volume intake (%)       65.8 ± 26.1                  34.9 ± 12.5              80.9 ± 15.5              \<0.001
  Fresh mother milk intake (%)       64.7 ± 42.6                  41.9 ± 43.7              75.9 ± 37.6              0.001

*Data are expressed as mean ± standard deviation. The percentage of human milk intake was computed from the volume of human milk intake compared with the total volume of milk intake during the hospital stay (fortified donor human milk + fortified fresh mother\'s milk+formula milk). Fresh mother milk intake (%) is the proportion of mothers\' own milk within the total volume of human milk*.

The mean energy and protein intake were 65.7 ± 16.4 Kcal/kg/day and 2.9 g/kg/day during the first week of life, 124.8 ± 13.8 kcal/kg/day and 3.3 ± 0.7 g/kg/day when full enteral feeding was achieved, and 130.8 ± 14.2 kcal/kg/day and 3.6 ± 0.6 g/kg/day at discharge, respectively. No differences in energy and protein intake between the two study groups were detectable during the hospital stay.

The weight z-score at birth and at discharge and the daily growth rates are shown in Table [4](#T4){ref-type="table"}.

###### 

Weight z-score and daily growth rate during hospital stay.

                                                             **All infants (*n* = 73)**   **Group 1 (*n* = 24)**   **Group 2 (*n* = 49)**   ***p***
  ---------------------------------------------------------- ---------------------------- ------------------------ ------------------------ ---------
  Birth weight z-score                                       −0.60 ± 0.97                 −0.61 ± 1.2              −0.59 ± 0.84             0.941
  Weight at discharge z-score                                −1.26 ± 1.01                 −1.14 ± 1.27             −1.32 ± 0.87             0.504
  Daily growth rate during parenteral nutrition (g/kg/day)   20.23 ± 5.38                 21.99 ± 4.35             19.4 ± 5.67              0.051
  Daily growth rate during full enteral feeding (g/kg/day)   15.32 ± 8.06                 18.65 ± 12.24            13.70 ± 4.17             0.013
  Total daily growth rate during hospital stay (g/kg/day)    16.07 ± 2.42                 17.30 ± 2.74             15.46 ± 2.01             0.002

*Data are expressed as mean ± standard deviation. The daily growth rates were calculated during the administration of parenteral nutrition, after reaching full enteral feeding (milk volume intake ≥150 ml/kg/day) and during all the hospital stay*.

No differences were found in weight z-score at birth or at discharge between the two groups. Group 1 had a higher growth rate than group 2 both after reaching full enteral feeding (milk volume intake≥150 ml/kg/day) and during the entire hospital stay.

The incidence of comorbidities developed during hospitalization was similar in group 1 and group 2. Among all infants included in the study, none developed NEC, 9.6% had cholestasis, 5.5% had bronchopulmonary dysplasia, 9.6% received treatment for patent ductus arteriosus, and 17.8% had sepsis.

The characteristics at discharge and at term CA according to the mode of feeding are shown in Tables [5](#T5){ref-type="table"}, [6](#T6){ref-type="table"}. No differences were found between the two groups regarding the anthropometric measurements and body composition at discharge or at term CA. The infants included in the study achieved the ability to feed orally beginning at 36.4 ± 1.4 weeks of postmenstrual age. No differences were found between groups.

###### 

Characteristics at discharge according to mode of feeding.

                              **All infants (*n* = 73)**   **Group 1 (*n* = 24)**   **Group 2 (*n* = 49)**   ***p***
  --------------------------- ---------------------------- ------------------------ ------------------------ ---------
  Weight (g)                  2404 ± 424                   2471 ± 514               2371 ± 373               0.349
  Length (cm)                 45.1 ± 2.2                   45.3 ± 2.2               44.9 ± 2.2               0.544
  Head Circumference (cm)     32.0 ± 2.0                   32.2 ± 1.7               31.9 ± 2.1               0.604
  Postmenstrual age (weeks)   37.7 ± 1.5                   37.8 ± 1.4               37.6 ± 1.6               0.470
  Length of stay (days)       51.9 ± 18.5                  52.8 ± 19.4              51.4 ± 18.1              0.763

*Data are expressed as mean ± standard deviation*.

###### 

Anthropometric measurements and body composition at term corrected age according to mode of feeding.

                            **All infants (*n* = 73)**   **Group 1 (*n* = 24)**   **Group 2 (*n* = 49)**   ***p***
  ------------------------- ---------------------------- ------------------------ ------------------------ ---------
  Weight (g)                3088 ± 476                   3142 ± 628               3062 ± 386               0.506
  Length (cm)               48.5 ± 2.3                   48.4 ± 2.7               48.6 ± 2.1               0.774
  Head Circumference (cm)   34.6 ± 1.3                   34.4 ± 1.7               34.7 ± 1.1               0.346
  Fat free mass (%)         82.0 ± 11.1                  78.6 ± 18.1              83.7 ± 4.5               0.067

*Data were expressed ad mean ± standard deviation*.

Multiple logistic regression analysis showed that there was a positive association between the human milk volume intake percentage and fat-free mass percentage after correction for birth weight and gender (β = 0.12 ± 0.05, *p* = 0.01). Specifically, the regression model showed that being fed with human milk at more than or equal to 50% of total milk intake was associated with a significant increase in fat-free mass percentage at term CA (Table [7](#T7){ref-type="table"}).

###### 

Multiple regression analysis model for fat free mass %.

                                           **Beta coefficients**   **95% Interval of confidence**   ***p***
  ---------------------------------------- ----------------------- -------------------------------- ---------
  Intercept                                95.518 ± 7.876          79.805; 111.231                  \<0.001
  Being male (no vs. yes)                  4.396 ± 2.481           −0.552; 9.345                    0.081
  Birth weight (g)                         −0.01 ± 0.006           −0.028; −0.003                   0.016
  Being fed human milk ≥50% (no vs. yes)   5.883 ± 2.638           0.621; 11.146                    0.029

*Multiple regression analysis model corrected by gender and birth weight. Being fed with human milk more than or equal to 50% was positively associated with a significant increase in fat free mass percentage at term CA*.

Discussion {#s4}
==========

This study examined the relationship between the type of feeding and body composition in VLBW infants. Specifically, we demonstrated that VLBW infants fed human milk (both fresh mother\'s milk and/or donor human milk) at more than or equal to 50% of the total milk volume intake during the hospital stay displayed an increased fat-free mass percentage at term CA compared to VLBW infants fed human milk at less than 50% of the total milk intake.

Johnson et al. demonstrated that VLBW infants had a fat-free mass deficit at term CA compared to full-term infants ([@B24]). Increasing evidence has demonstrated that greater fat-free mass deposition is associated with an improved neurodevelopmental outcome ([@B25]). A study conducted at our center demonstrated that human milk feeding is positively associated with fat-free mass deposition in late preterm infants ([@B8]).

Our results showed that infants fed human milk at less than 50% of the total milk intake had a higher growth rate than their counterparts. On the other hand, the weight and weight z-score at discharge were similar between the two groups. It must be noted that most of the infants fed fresh mother\'s milk were in group 2, and consequently, the higher number of breastfed infants can explain the lower growth rate in these infants than in formula-fed infants. Indeed, after reaching full enteral feeding and, above all, after reaching the ability to feed orally, breastfed infants cannot receive adequate fortification from feedings taken directly from the breast. A similar weight was found at term CA between the two groups. Indeed, considering the weight increase percentage between discharge and term CA, infants in group 2 show a slightly higher value than those in group 1 (+31.4 vs. 28.3%), probably due to better adaptation of group 2 infants than group 1 infants after discharge.

To the best of our knowledge, this was the first study to explore the modulating effect of both fresh mother\'s milk and donor human milk on body composition. In a previous study conducted in our center, Morlacchi et al. demonstrated that preterm infants fed fortified mother\'s own milk showed a higher percentage of fat-free mass than formula-fed infants at term CA, which was probably due to the higher nitrogen balance in breastfed infants than in formula-fed infants ([@B12]). In our study, we did not evaluate infant nitrogen balance; however, we can speculate that being fed both fortified fresh mother\'s milk and/or donor human milk can result in a similar metabolic response to that obtained by feeding exclusively fresh mother\'s milk. In addition, in the univariate regression analysis, the percentage of fresh mother\'s milk intake was not associated with FFM deposition, whereas the total human milk volume intake was positively associated with the FFM percentage at term CA. This observation can most likely be explained by the relatively low percentage of fresh human milk ingested by infants included in the study.

It has been reported that exclusive breastfeeding is associated with lower growth rates in preterm infants than formula feeding ([@B26]), especially with standard fortification of human milk ([@B27]). In fact, the mean protein content decreases during lactation, while the nutrient needs of VLBW infants remain high ([@B28], [@B29]). In addition, although it has been reported that donor human milk provides nutrients comparable to mother\'s milk, preterm infants fed donor human milk fortified similarly to fresh mother\'s milk according to standard methods showed an increased risk of postnatal growth restriction ([@B30], [@B31]). In contrast, it has been reported that fortification of donor human milk to reach 3.5 g/kg of protein intake is associated with significantly greater weight gain and head growth in VLBW infants than feeding a formula-based diet ([@B30]). In addition, targeted fortification of human milk seems to represent an optimal strategy to prevent postnatal growth restriction ([@B32], [@B33]).

According to our internal procedure, when infants tolerated an enteral intake of human milk (both fresh mother\'s milk and/or donor human milk) ≥80 ml/kg/day, targeted human milk fortification is initiated to meet the ESPGHAN guidelines. Consequently, infants fed fortified human milk at more than or equal to 50% of the total milk volume intake during the hospital stay exhibited similar growth at discharge as infants fed less human milk.

In a recent study of 34 VLBW infants (11 breastfed and 23 formula-fed) compared with a control group of 19 full-term infants, it was demonstrated that formula-fed infants were heavier than breastfed infants at term CA and showed higher amounts of adipose tissue and lower amounts of fat-free mass than full-term infants. However, breastfed preterm infants had a similar body composition as full-term infants ([@B34], [@B35]).

In our study, we did not observe any difference in body weight between the two groups, irrespective of the type of feeding, both at discharge and at term CA. Nevertheless, infants in group 2 who were fed \~81% human milk during their hospital stay had an increased fat-free mass at term CA compared with infants in group 1 who were fed only 35% human milk from birth to discharge.

It has been taken into account that in our study, the donor human milk constituted 58% and 25% of the total amount of human milk intake in group 1 and group 2, respectively. This detail underlines the important effect of fresh mother\'s milk on growth and quality of growth but suggests that donor human milk is preferred over formula milk when fresh mother\'s milk is not available or is insufficient to satisfy the infant\'s nutritional needs. Therefore, the strength of the study was the use of donor human milk to supplement fresh mother\'s milk and the practice of targeted fortification to achieve the nutritional needs of preterm infants.

It must also be taken into account that the infants included in this study were all clinically stable at term CA during the assessment of body composition, and therefore, the results obtained in this study cannot be applied to sick infants. In addition, a limitation of the study is that it is not a randomized controlled trial, although this type of study design has ethical issues.

In conclusion, the use of target fortified human milk modulated the growth of and improved the quality of growth in vulnerable preterm infants. The use of fortified donor human milk when fresh mother\'s milk is insufficient or not available should be encouraged.
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